The acquisition, when completed, means that Cord Blood America will control over 100,000 customers internationally, and expects its combined revenues to be in the $14M range annually if all businesses continue the same sales rate.
When you think about it, that's really small numbers-wise. Peanuts. I don't see the company value increasing much over the next few years. Really, storing cord blood is not a money maker. Probably was the wrong business to get into. That's why Cryocell sold.
70k since 2001 for Cyro-cell Mexico is not very impressive at all.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.